Mechanism based medicine in infancy: complex interplay between developmental pharmacology and pharmacogenetics

Area of Science:

• Pharmacology
• Genetics
• Personalized Medicine

Background:

• Pharmacogenetics is key to advancing individualized medicine.
• Current approaches often focus on population data, creating a gap with individual patient needs.
• Understanding drug response variability is crucial for effective treatment.

Purpose of the Study:

• To highlight the importance of pharmacogenetics in personalized medicine.
• To demonstrate the need to integrate pharmacogenetics with other covariates for tailored pharmacotherapy.
• To extend existing examples illustrating complex drug interactions.

Main Methods:

• Literature review and synthesis of existing knowledge.
• Extension of a previous case study (tramadol example).
• Analysis of multiple covariates influencing drug response.

Main Results:

• Pharmacogenetics is a vital tool for bridging the evidence-based and mechanistic medicine gap.
• Tailored pharmacotherapy necessitates a multifactorial approach, including pharmacogenetics, age, renal function, and co-medication.
• The extended tramadol example showcases the intricate relationship between developmental pharmacology and pharmacogenetics.

Conclusions:

• Integrating pharmacogenetics with clinical factors is essential for optimizing drug therapy.
• A holistic approach is required for truly personalized pharmacotherapy.
• Further research into the interplay of multiple factors is needed to refine individualized treatment strategies.